Concentrix Corporation (CNXC) Drops 3.10% After Earnings

2026-06-29 · Stocks · QuoteReporter

Post Earning Analysis

Concentrix Corporation (CNXC) Drops 3.10% After Earnings

The current price of the stock is $24.225, marking a decline of $3.10 today. The Relative Strength Index (RSI) at 44.05 suggests the stock is neither overbought nor oversold, leaning slightly towards a bearish sentiment. The Moving Average Convergence Divergence (MACD) at -0.62 indicates negative momentum, suggesting the possibility of a continued downtrend.

The stock is trading below both its 50-day and 200-day moving averages by 5.78% and 30.53%, respectively, indicating a bearish trend and a lack of support in the medium to long term. Currently, the stock is positioned closer to its 52-week low of $22.05 than its high of $59.94, highlighting significant bearish pressure over the past year.

The price action, combined with its position relative to its moving averages and the negative MACD, implies a negative market sentiment towards this stock. The proximity to the 52-week low further underscores the cautious or pessimistic outlook investors have regarding its near-term prospects.

Earnings Trend Table

The earnings per share (EPS) trend for the company has shown fluctuations over the recent quarters, with a notable pattern of volatility rather than a clear direction of growth or decline. Starting from Q3 2023, the EPS was reported at 2.71, missing estimates. This trend of missing expectations continued into Q1 2024, with an EPS of 3.36, although it exceeded the estimate significantly. The following quarters in 2024 showed mixed results; Q2 and Q3 2024 EPS were 2.69 and 2.87, respectively, with Q2 slightly beating and Q3 missing estimates.

The year 2025 began with a strong performance in Q1, where EPS reached 3.26, again surpassing expectations. However, a turning point appeared in Q2 2025, with a reported EPS of 2.79, which, while above the estimate, marked a decrease from the previous quarter. The most recent data from Q3 2025 shows a further decline to an EPS of 2.70, missing the estimate.

This trend of recent misses and the latest decline in EPS could undermine the investment thesis if the pattern continues, suggesting potential challenges in maintaining profitability or facing operational headwinds. Given the recent downward trajectory, the next quarter's consensus might be at risk, especially if the underlying issues are not addressed promptly.

Dividend Payments Table

The dividend data indicates a pattern of growth in the payouts over recent quarters. Specifically, the dividend has increased from $0.303 in July 2024 to $0.36 by April 2026. This represents a growth from $0.303 to $0.333, and subsequently to $0.36, marking a clear upward trajectory in the dividend amount.

Calculating the compound annual growth rate (CAGR) from July 2024 to April 2026, the dividend has grown at a rate of approximately 8.9% per annum. This growth rate is a positive indicator of the company's ability to increase its dividend payouts, reflecting potentially strong financial health and a commitment to returning value to shareholders.

However, without specific data on the company's earnings or free cash flow relative to its dividend payouts, it's challenging to fully assess the sustainability of these dividends. If the company's free cash flow adequately covers the dividend payments, this would further affirm the attractiveness of the stock for income investors, especially when compared to fixed income alternatives like the 10-year Treasury, which typically offers lower yields.

The recent history of consistent dividend increases could be seen as a signal of management's confidence in the company's financial stability and future prospects. This profile, assuming sustainable payouts, would likely make the stock appealing to income-focused investors seeking growth in their dividend income.

The most recent Wall Street rating changes for the stock in question show a mix of opinions, reflecting a somewhat divided sentiment among analysts. On March 24, 2025, Barrington Research reiterated an "Outperform" rating but lowered the target price from $70 to $54. Earlier, on October 3, 2024, Robert W. Baird initiated coverage with an "Outperform" rating and a target price of $70. BofA Securities made two moves: on August 28, 2024, they upgraded the stock from "Underperform" to "Neutral" and raised their target from $65 to $85, and previously on March 27, 2024, they downgraded it from "Neutral" to "Underperform," lowering their target from $85 to $60.

The consensus among these analysts suggests a cautious optimism, with a notable range in target prices from $54 to $85. This range indicates that while some analysts see potential for significant appreciation, others remain more conservative. The most bullish target of $85 by BofA Securities stands out, especially considering their previous bearish stance, suggesting a reassessment of the stock's fundamentals or market conditions.

Given this information, investors might find the consensus somewhat reliable but should be aware of the underlying uncertainties and divergences in opinion. The wide range in target prices suggests that while there is potential upside, the market's divided views could also reflect varying degrees of risk. Therefore, trusting the consensus would require a balanced view of the stock's potential against its risks, leaning towards a cautiously optimistic investment approach.

With a current price of $24.23 and a consensus target price of $66.33 (average of the most recent targets at $54, $70, and $85), the stock presents a significant upside potential of +174%. This substantial gap suggests that the market may be undervaluing the company's prospects or overestimating its risks.

The recent analyst actions, including upgrades and price target adjustments, indicate a positive shift in expectations, despite the current low stock price. This discrepancy between analyst targets and market price may suggest that the market is underpricing the company's potential for recovery or growth, or possibly overlooking recent positive developments.

A critical forward catalyst to watch is the company's next quarterly earnings report. Should the reported earnings significantly beat expectations or show notable improvement in key areas like revenue growth or margin expansion, it would likely validate the bullish analyst sentiment and could lead to a rapid re-rating of the stock closer to its target prices. Conversely, failure to meet or exceed these expectations could reinforce the market's current skepticism.